Substituted 4,6-Diaminoquinolines as Inhibitors of C5a Receptor Binding

Journal of Medicinal Chemistry

Volumn 35, Issue 2, 1992, Pages 252-258

  Lanza, Thomas J ^a   Durette, Philippe L ^a   Caldwell, Charles G ^a   Hagmann, William K ^a   Rollins, Thomas ^a   Siciliano, Salvatore ^a   Kobayash, Sumireb V ^a   Springer, Martin S ^a  

^a Department of Medicinal Chemistry Research ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINURIDE; COMPLEMENT RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOTRIENE; N (4 BENZYLAMINO 2 METHYL 6 QUINOLYL) 2 CHLOROCINNAMIDE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; DEGRANULATION; HUMAN; HUMAN CELL; NEUTROPHIL; PREVENTION; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

AMINOQUINOLINES; CELL DEGRANULATION; COMPLEMENT 5A; HUMAN; IN VITRO; LEUKOTRIENE B4; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; RECEPTORS, COMPLEMENT; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0026544373     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00080a008     Document Type: Article

References (27)

1. Hugli, T. E. The Structural Basis for Anaphylatoxin and Chemotactic Functions of C3a, C4a, and C5a. CRC Crit. Rev. Immunol. 1981, 1, 321-366.
2. Vogt, W. Activation of the Complement System. Agts. Actions 1983, 13, 391-397.
3. Greer, J. Comparative Structural Anatomy of the Complement Anaphylatoxin Proteins C3a, C4a, and C5a. Enzyme 1986, 36, 150-163.
4. Egwang, T. G.; Befus, A. D. The Role of Complement in the Induction and Regulation of Immune Responses. Immunology 1984, 51, 207-224.
5. Weigle, W. O.; Goodman, M. G.; Morgan, E. L.; Hugli, T. E. Regulation of Immune Response by Components of the Complement Cascade and Their Activated Fragments. Springer Semin. Immunopathol. 1983, 6, 173-194.
6. Yancey, K. B. Biological Properties of Human C5a: Selected in vitro and in vivo Studies. Clin. Exp. Immunol. 1988, 71, 207-210.
7. Schindler, R.; Lonnemann, G.; Stanley, S.; Koch, K.-M.; Dinarello, C. A. Transcription, not Synthesis, of Interleukin-1 and Tumor Necrosis Factor by Complement. Kidney International 1990, 37, 85-93.
8. Zuiderweg, E. R. P.; Nettesheim, D. G.; Mollison, K. W.; Carter, G. W. Tertiary Structure of Human Complement Component C5a in Solution from Nuclear Magnetic Resonance Data. Biochemistry 1989, 28, 172-185.
9. Williamson, M. P.; Madison, V. S. Three-Dimensional Structure of Porcine CS adesArg from 1H Nuclear Magnetic Resonance Data. Biochemistry 1990, 29, 2895-2905.
10. Chenoweth, D. E.; Hugli, T. E. Demonstration of Specific C5a Receptor on Intact Human Polymorphonuclear Leukocytes. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 3943-3947.
11. Johnson, R. J.; Tamerius, J. D.; Chenoweth, D. E. Identification of an Antigenic Epitope and Receptor Binding Domain of Human C5a. J. Immunol. 1987, 138, 3856-3862.
12. Mollison, K. W.; Mandecki, W.; Zuiderweg, E. R. P.; Payer, L.; Fey, T. A.; Krause, R. A.; Conway, R. G.; Miller, L.; Edalji, R. P.; Shallcross, M. A.; Lane, B.; Fox, J. L.; Greer, J.; Carter, G. W. Identification of Receptor Binding Residues in the Inflammatory Complement Protein C5a by Site-Directed Mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 292-296.
13. Chenoweth, D. E.; Hugli, T. E. Human C5a and C5a Analogs as Probes of the Neutrophil C5a Receptor. Molec. Immunol. 1980, 17, 151-161.
14. Gerard, C.; Showell, H. J.; Hoeprich, P. D.; Hugli, T. E.; Stimler, N. P. Evidence for the Role of the Amino-terminal Region in the Biological Activity of the Classical Anaphylatoxin, Porcine C5a des-Arg-74. J. Biol. Chem. 1985, 260, 2613-2616.
15. Kawai, M.; Quincy, D. A.; Lane, B.; Mollison, K. W.; Luly, J. A.; Carter, G. W. Identification and Synthesis of a Receptor Binding Site of Human Anaphylatoxin C5a. J. Med. Chem. 1991, 34, 2068-2071.
16. Olsen, U. B.; Selmer, J.; Kahl, J.-U. Complement C5a Receptor Antagonism by Protamine and Poly-L-Arg on Human Leukocytes. Complement 1988, 5, 153-162.
17. Gerard, N. P.; Gerard, C. The Chemotactic Receptor for Human C5a Anaphylatoxin. Nature 1991, 349, 614-617.
18. Jensch, H. Neue Chemotherapeutika der 4-Amino-chinolin-Reihe. Angew. Chem. 1937, 50, 891-902.
19. Peng, C.-T.; Daniels, T. C. The Synthesis of Some 6-N-Substituted Amide Derivatives of 4,6-Diaminoquinaldine and a Study of their in vitro Antibacterial Activity. J. Am. Chem. Soc. 1956, 78, 3703-3708.
20. Pratt, M. G.; Archer, S. The Preparation of Some Amides of 4,6-Diaminoquinaldine. J. Am. Chem. Soc. 1948, 70, 4065-4069.
21. Schock, R. U. The Preparation of Some N,N′-Bis-(4-quinaldyl)-a,o-diaminoalkanes as Potential Trypanocides. J. Am. Chem. Soc. 1957, 79, 1672-1675.
22. Rollins, T. E.; Springer, M. S. Identification of the Polymorphonuclear Leukocyte C5a Receptor. J. Biol. Chem. 1985, 260, 7157-7160.
23. Rollins, T. E.; Siciliano, S.; Springer, M. S. Solubilization of the Functional C5a Receptor from Human Polymorphonuclear Leukocytes. J. Biol. Chem. 1988, 264, 520-526.
24. English, D.; Andersen, B. R. Single-step Separation of Red Blood Cells, Granulocytes, and Mononuclear Phagocytes on Discontinuous Density Gradients of Ficoll-Hypaque. J. Immunolog. Methods 1974, 5, 249-255.
25. Hunter, D. T.; Hill, J. M. Surfen: A Quinoline with Oncogenic and Heparin-Neutralizing Properties. Nature 1961, 191, 1378-1379.
26. DeLean, A.; Munson, P. J.; Rodbard, D. Simultaneous Analysis of Families of Sigmoidal Curves: Application to Bioassay, Radioligand Assay, and Physiological Dose-Response Curves. Am. J. Physiol. 1978, 235, E97-E102.
27. Haskelberg, L. Derivatives of 6-Nitro and 6-Aminoquinoline. J. Org. Chem. 1947, 12, 434-436.